Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.59 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.57 |
| ▸ | PPARG | P37231 | 7/20 | 0.57 |
| ▸ | PPARD | Q03181 | 7/20 | 0.57 |
| ▸ | PPARA | Q07869 | 7/20 | 0.57 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.57 |
| ▸ | TSHR | P16473 | 4/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.57 |
| ▸ | FABP4 | P15090 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | TLR2 | O60603 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.57 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | ESR1 | P03372 | 1/20 | 0.57 |
| ▸ | PDE4A | P27815 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Myristic Acid SCHEMBL3299115 | 0.98 | GPR84 (0.61) | AKR1B1GPR84PPARGPPARDPPARA | |
| Palmitic Acid SCHEMBL1815959 | 0.98 | GPR84 (0.61) | AKR1B1GPR84PPARGPPARDPPARA | |
| Stearic Acid SCHEMBL4612415 | 0.98 | GPR84 (0.61) | AKR1B1GPR84PPARGPPARDPPARA | |
| Valeric Acid SCHEMBL29098873 | 0.94 | AKR1B1 (0.50) | AKR1B1GPR84PPARGPPARDPPARA | |
| Adipic Acid SCHEMBL29427201 | 0.90 | LMNA (0.50) | AKR1B1GPR84PPARGPPARDPPARA | |
| Adipic Acid SCHEMBL906129 | 0.90 | LMNA (0.50) | AKR1B1GPR84PPARGPPARDPPARA | |
| Oleic Acid SCHEMBL28630252 | 0.89 | PPARG (0.68) | PPARGPPARDPPARATSHRPTPN1 | |
| Azelaic Acid SCHEMBL28918234 | 0.88 | TSHR (0.52) | GPR84PPARGPPARDPPARAHDAC11 | |
| Glutarate SCHEMBL9485824 | 0.86 | SLC22A6 (0.50) | GPR84HDAC11TSHRKMT2ASLC22A6 | |
| Glutarate SCHEMBL28487046 | 0.86 | SLC22A6 (0.50) | GPR84HDAC11TSHRKMT2ASLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105477641-B | Biosynthetic proline/alanine random coil polypeptides and uses thereof | XL-蛋白有限责任公司 | 2021-03-23 | — | — | CN | disclosed |
| EP-2106812-B1 | Methods of Making and Using Surfactant Polymers | NANOMIMETICS INC (US) | 2016-01-13 | — | — | EP | disclosed |
| US-9125969-B2 | Methods of making and using surfactant polymers | NANOMIMETICS, INC. (US) | 2015-09-08 | — | — | US | disclosed |
| US-9012413-B2 | FGF receptor-activating N-acyl octasaccharides, preparation thereof, and therapeutic use thereof | SANOFI (FR) | 2015-04-21 | — | — | US | disclosed |
| US-20120245288-A1 | METHODS OF MAKING AND USING SURFACTANT POLYMERS | NANOMIMETICS, INC. (US) | 2012-09-27 | — | — | US | disclosed |
| US-20120214754-A1 | FGF RECEPTOR-ACTIVATING N-ACYL OCTASACCHARIDES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF | SANOFI (FR) | 2012-08-23 | — | — | US | disclosed |
| US-8163302-B2 | Methods of making and using surfactant polymers | NANOMIMETICS, INC. (US) | 2012-04-24 | — | — | US | disclosed |
| EP-2106812-A2 | Methods of Making and Using Surfactant Polymers | NanoMimetics, Inc. (US) | 2009-10-07 | — | — | EP | disclosed |
| US-7544774-B2 | Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2009-06-09 | — | — | US | disclosed |
| US-20080262614-A1 | METHODS OF MAKING AND USING SURFACTANT POLYMERS | NANOMIMETICS, INC. (US) | 2008-10-23 | — | — | US | disclosed |
| EP-1073682-B1 | HEPARANASE SPECIFIC MOLECULAR PROBES AND THEIR USE IN RESEARCH AND MEDICAL APPLICATIONS | INSIGHT BIOPHARMACEUTICALS LTD (IL) | 2006-05-31 | — | — | EP | disclosed |
| WO-2005115492-A1 | ABSORBABLE BIOCOMPATIBLE MATERIALS | BIOINTERACTIONS LTD (GB) | 2005-12-08 | — | — | WO | disclosed |
| US-20050153369-A1 | Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX | MILLER JONATHAN L (US) | 2005-07-14 | — | — | US | disclosed |
| EP-1073682-A1 | HEPARANASE SPECIFIC MOLECULAR PROBES AND THEIR USE IN RESEARCH AND MEDICAL APPLICATIONS | Insight Strategy & Marketing Ltd. (IL) | 2001-02-07 | — | — | EP | disclosed |
| EP-1073682-A4 | HEPARANASE SPECIFIC MOLECULAR PROBES AND THEIR USE IN RESEARCH AND MEDICAL APPLICATIONS | INSIGHT STRATEGY & MARKETING (IL) | 2001-02-07 | — | — | EP | disclosed |
| WO-1999057153-A1 | HEPARANASE SPECIFIC MOLECULAR PROBES AND THEIR USE IN RESEARCH AND MEDICAL APPLICATIONS | INSIGHT STRATEGY & MARKETING LTD. (IL) | 1999-11-11 | — | — | WO | disclosed |
| US-5877155-A | EXPOSURE OF PLATELETS TO THE MOLECULE (ANTI-MIMOTOPE) IN ORDER TO MODULATE ADHESION, AGGREGATION, OR AGGLUTINATION OF THE PLATELETS. | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1999-03-02 | — | — | US | disclosed |
| EP-0876396-A1 | MIMOTOPES AND ANTI-MIMOTOPES OF HUMAN PLATELET GLYCOPROTEIN Ib/IX | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1998-11-11 | — | — | EP | disclosed |
| WO-1997018236-A9 | MIMOTOPES AND ANTI-MIMOTOPES OF HUMAN PLATELET GLYCOPROTEIN Ib/IX | — | 1997-10-23 | — | — | WO | disclosed |
| WO-1997018236-A1 | MIMOTOPES AND ANTI-MIMOTOPES OF HUMAN PLATELET GLYCOPROTEIN Ib/IX | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1997-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120214754-A1 | FGF RECEPTOR-ACTIVATING N-ACYL OCTASACCHARIDES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF | FGFR1, FGF2, FGFR3 | AKR1B1 710/4885GPR84 102/4885PPARG 2020/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.